Modern Wealth Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.35M Buy
6,354
+855
+16% +$168K 0.02% 456
2026
Q1
$1.09M Buy
5,499
+104
+2% +$20.2K 0.02% 408
2025
Q4
$936K Sell
5,395
-109
-2% -$19.8K 0.02% 414
2025
Q3
$1.05M Sell
5,504
-39
-0.7% -$6.92K 0.02% 385
2025
Q2
$996K Buy
5,543
+14
+0.3% +$2.43K 0.02% 371
2025
Q1
$935K Buy
5,529
+403
+8% +$66.2K 0.03% 311
2024
Q4
$773K Buy
5,126
+286
+6% +$44.5K 0.03% 295
2024
Q3
$752K Buy
4,840
+174
+4% +$26K 0.05% 195
2024
Q2
$639K Sell
4,666
-293
-6% -$40.1K 0.05% 185
2024
Q1
$660K Buy
+4,959
New +$643K 0.06% 144

Other funds holding DGX

Modern Wealth Management's DGX Position: Q2 2026 in Review

Modern Wealth Management increased its Quest Diagnostics (DGX) stake by 16% in Q2 2026, buying an estimated $168K and bringing the position to 6,354 shares worth $1.35M. The position accounts for 0.02% of the portfolio, ranked #456.

Modern Wealth Management first reported a position in DGX in Q1 2024 and has held it in 10 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Modern Wealth Management held 6,354 shares of Quest Diagnostics worth $1.35M as of Q2 2026.
  • Modern Wealth Management bought 855 Quest Diagnostics shares in Q2 2026, an estimated $168K.
  • Quest Diagnostics made up 0.02% of Modern Wealth Management's portfolio in Q2 2026, its #456 holding.
  • Modern Wealth Management first reported a position in Quest Diagnostics in Q1 2024 and has held it in 10 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Modern Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.